10 / 20
Page 42
Der Pharmacia Sinica
ISSN: 0976-8688
Eurosc i con Conference on
Medicinal Chemistry
and Biosimilars
M a r c h 2 5 - 2 6 , 2 0 1 9
B u d a p e s t , H u n g a r y
Medicinal Chemistry & Biosimilars 2019
T
he strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade and has had a
positive result on government deficit. The investment law approved recently has good statements and rules on the above
strategy in particular to pharmacy regulations. Under the pressure of the new privatisation policy, the government introduced
radical changes in the pharmacy regulations. To improve the effectiveness of the public pharmacy, resources should be switched
towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through cost
sharing or full private. The role of the private services is significant. A review of reform of financing medicines in Sudan is given
in this study. Also, it highlights the current drug supply system in the public sector, which is currently the responsibility of Central
Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or quantitative
studies about the impact of drug regulations on the quality of medicines and how to protect public health against counterfeit or
low quality medicines, although it is practically possible. However, the regulations must be continually evaluated to ensure the
public health is protected against by marketing high quality medicines rather than commercial interests, and the drug companies
are held accountable for their conduct.
abdeenomer2@yahoo.co.ukThe present policy of the national healthcare
system in Sudan
Abdeen M Omer
Occupational safety and Health Administration, Sudan
Der Pharmacia Sinica 2019, Volume:10
DOI: 10.21767/0976-8688-C1-003